220 filings
Page 4 of 11
8-K
s2z15ozeheky8q
12 Jan 22
Other Events
4:05pm
8-K
4z4az ekxh9jp
10 Jan 22
Other Events
4:07pm
8-K
xz4bwuamn9i s8yog
6 Jan 22
Other Events
9:06am
8-K
qmckr winegh4l
30 Dec 21
Other Events
4:27pm
8-K
qv7jkrrv
15 Dec 21
Departure of Directors or Certain Officers
5:20pm
8-K
gr52h2xmqurh82ajrl
15 Dec 21
Other Events
8:26am
8-K
rg3068urh5zo fmx0
9 Dec 21
Other Events
9:01am
8-K
6l3k733ohv5uqet4v8
26 Nov 21
Ocugen, Inc. Provides an Update on its Investigational New Drug Application with U.S. FDA to Initiate a Phase 3 Clinical Trial Evaluating
7:38am
8-K
2465i9h2ekwp
15 Nov 21
Other Events
4:03pm
8-K
6ah 3jr0m
9 Nov 21
Other Events
7:41am
8-K
1um9199j23q6
9 Nov 21
Ocugen Provides Business Update and Third Quarter 2021 Financial Results
7:35am
8-K
18cu0pk59pfxjk
8 Nov 21
Ocugen, Inc. Announces Submission of Investigational New Drug Application
9:25am
8-K
xymvuv 24ibtne3e
5 Nov 21
Other Events
8:00am
8-K
tyx2h4gqr7 zi28uub4
2 Nov 21
Other Events
4:47pm
8-K
xsmj40l
27 Oct 21
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
8:10am
8-K
zqcctmp y6
4 Oct 21
Entry into a Material Definitive Agreement
4:17pm
8-K
87bn h961mp
15 Sep 21
Regulation FD Disclosure
4:56pm
8-K
1ydq9p9b1ws4mr5 mj
8 Sep 21
Other Events
7:31am
8-K
ogroirp5a gl
6 Aug 21
Ocugen Provides Business Update and Second Quarter 2021 Financial Results
7:40am
8-K
urgot2nh f3u
20 Jul 21
Other Events
7:26am